Fabry disease (FD), an X-linked metabolic disorder, results from pathogenic variants in the GLA gene that cause functional haploinsufficiency of the lysosomal enzyme alpha-galactosidase A, leading to accumulation of glycosphingolipids like Gb3 and lyso-Gb3 throughout the body. This evidence concerns the gene GLA and metabolic disease.